🔎 Trials Near Me

Beranda › Penyakit Hati Steatotik › California › Los Angeles

Uji klinis Penyakit Hati Steatotik di Los Angeles, CA

8 studi untuk Penyakit Hati Steatotik mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Menerima pesertaFase 3
  • 89bio Clinical Study Site, Los Angeles
  • 89bio Clinical Study Site, Los Angeles
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06419374

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Menerima pesertaFase 2
  • Keck Medical Center of USC, Los Angeles
  • LAC + USC Medical Center, Los Angeles
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05832229

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Menerima pesertaFase 3
  • Los Angeles Institute for Metabolic Research, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Menerima pesertaFase 3
  • Akero Clinical Study Site, Los Angeles
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Menerima pesertaFase 3
  • GSK Investigational Site, Los Angeles
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07221188

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Menerima pesertaFase 2
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Menerima pesertaFase 3
  • GSK Investigational Site, Los Angeles
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07221227

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • Velocity Clinical research, Los Angeles
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT05648214

Uji klinis Penyakit Hati Steatotik di kota lain

Studi lain di Los Angeles

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.